Cytheris is a startup based in Germany, most recent round Acquired, 1 tracked investor.
Based in Germany, Cytheris is a startup. Cytheris has been acquired. Brouky records 1 investor associated with the company.
Cytheris was a biopharmaceutical company that developed immunotherapies. It focused on using recombinant human Interleukin-7 (r-hIL-7) to treat immune deficiencies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.